Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 8Recurrence 3Astrocytoma 3Gliosarcoma 2Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Pituitary Neoplasms 1Oligodendroglioma 1Non Small Cell Lung Cancer Metastatic 1Melanoma 1Medulloblastoma 1Glioma 1Ependymoma 1Brain Neoplasms 1Advanced Glioblastoma 1

Interventions

Temozolomide 1Radiotherapy, Intensity-Modulated 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Advanced Glioblastoma × Temozolomide × Clear all
NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Not yet recruiting
422 enrolled
CNS

Advanced Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡